In addition, RIG-I low expression level is correlated with poor prognosis in patients with HCC [10], melanoma [13], and gastric cancer [33], and is an independent favorable prognostic factor in patients with estrogen receptor-positive breast cancer. Here, ESR1 is linked to melanoma.